WO1994012192A1
(en)
|
1992-12-01 |
1994-06-09 |
Commonwealth Scientific And Industrial Research Organisation |
Antiviral agents
|
DE69332616T2
(de)
|
1992-12-29 |
2003-11-06 |
Abbott Laboratories, Abbott Park |
Hemmer der retroviralen Protease
|
IL110752A
(en)
|
1993-09-13 |
2000-07-26 |
Abbott Lab |
Liquid semi-solid or solid pharmaceutical composition for an HIV protease inhibitor
|
US5559158A
(en)
|
1993-10-01 |
1996-09-24 |
Abbott Laboratories |
Pharmaceutical composition
|
IL111991A
(en)
|
1994-01-28 |
2000-07-26 |
Abbott Lab |
Liquid pharmaceutical composition of HIV protease inhibitors in organic solvent
|
US6037157A
(en)
|
1995-06-29 |
2000-03-14 |
Abbott Laboratories |
Method for improving pharmacokinetics
|
US6054472A
(en)
|
1996-04-23 |
2000-04-25 |
Vertex Pharmaceuticals, Incorporated |
Inhibitors of IMPDH enzyme
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
AU723730B2
(en)
|
1996-04-23 |
2000-09-07 |
Vertex Pharmaceuticals Incorporated |
Urea derivatives as inhibitors of IMPDH enzyme
|
WO1997043310A1
(en)
|
1996-05-10 |
1997-11-20 |
Schering Corporation |
Synthetic inhibitors of hepatitis c virus ns3 protease
|
HU227742B1
(en)
|
1996-10-18 |
2012-02-28 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
GB9623908D0
(en)
|
1996-11-18 |
1997-01-08 |
Hoffmann La Roche |
Amino acid derivatives
|
WO1998040381A1
(en)
|
1997-03-14 |
1998-09-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of impdh enzyme
|
GB9707659D0
(en)
|
1997-04-16 |
1997-06-04 |
Peptide Therapeutics Ltd |
Hepatitis C NS3 Protease inhibitors
|
DE69829381T2
(de)
|
1997-08-11 |
2006-04-13 |
Boehringer Ingelheim (Canada) Ltd., Laval |
Hepatitis c inhibitor peptide
|
ATE283865T1
(de)
|
1997-08-11 |
2004-12-15 |
Boehringer Ingelheim Ca Ltd |
Peptidanaloga mit inhibitorischer wirkung auf hepatitis c
|
IT1299134B1
(it)
|
1998-02-02 |
2000-02-29 |
Angeletti P Ist Richerche Bio |
Procedimento per la produzione di peptidi con proprieta' inibitrici della proteasi ns3 del virus hcv, peptidi cosi' ottenibili e peptidi
|
ES2281170T3
(es)
|
1998-03-31 |
2007-09-16 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de serina proteasas, particularmente proteasa ns3 del virus de la hepatitis c.
|
GB9812523D0
(en)
|
1998-06-10 |
1998-08-05 |
Angeletti P Ist Richerche Bio |
Peptide inhibitors of hepatitis c virus ns3 protease
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
DE19836514A1
(de)
|
1998-08-12 |
2000-02-17 |
Univ Stuttgart |
Modifikation von Engineeringpolymeren mit N-basischen Gruppe und mit Ionenaustauschergruppen in der Seitenkette
|
GB9825946D0
(en)
|
1998-11-26 |
1999-01-20 |
Angeletti P Ist Richerche Bio |
Pharmaceutical compounds for the inhibition of hepatitis C virus NS3 protease
|
ES2405316T3
(es)
|
1999-03-19 |
2013-05-30 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de la enzima IMPDH
|
US6608027B1
(en)
|
1999-04-06 |
2003-08-19 |
Boehringer Ingelheim (Canada) Ltd |
Macrocyclic peptides active against the hepatitis C virus
|
UA74546C2
(en)
|
1999-04-06 |
2006-01-16 |
Boehringer Ingelheim Ca Ltd |
Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
|
EP1206449A1
(en)
|
1999-07-26 |
2002-05-22 |
Bristol-Myers Squibb Company |
Lactam inhibitors of hepatitis c virus ns3 protease
|
US7122627B2
(en)
|
1999-07-26 |
2006-10-17 |
Bristol-Myers Squibb Company |
Lactam inhibitors of Hepatitis C virus NS3 protease
|
US6770666B2
(en)
|
1999-12-27 |
2004-08-03 |
Japan Tobacco Inc. |
Fused-ring compounds and use thereof as drugs
|
CN1623984A
(zh)
|
1999-12-27 |
2005-06-08 |
日本烟草产业株式会社 |
稠环化合物及其药物用途
|
EP1261611A2
(en)
|
2000-02-29 |
2002-12-04 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of hepatitis c virus ns3 protease
|
WO2001074768A2
(en)
|
2000-04-03 |
2001-10-11 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
KR20030036152A
(ko)
|
2000-04-05 |
2003-05-09 |
쉐링 코포레이션 |
N-사이클릭 p2 잔기를 포함하는 c형 간염 바이러스의매크로사이클릭 ns3-세린 프로테아제 억제제
|
WO2001077091A2
(en)
|
2000-04-05 |
2001-10-18 |
Tularik Inc. |
Ns5b hcv polymerase inhibitors
|
MXPA02010375A
(es)
|
2000-04-19 |
2003-04-25 |
Schering Corp |
Inhibidores macrociclicos de la ns3-serina proteasa del virus de la hepatitis c que comprenden porciones alquil y arilalanina p2.
|
US6448281B1
(en)
|
2000-07-06 |
2002-09-10 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
GB0017676D0
(en)
|
2000-07-19 |
2000-09-06 |
Angeletti P Ist Richerche Bio |
Inhibitors of viral polymerase
|
AR034127A1
(es)
|
2000-07-21 |
2004-02-04 |
Schering Corp |
Imidazolidinonas como inhibidores de ns3-serina proteasa del virus de hepatitis c, composicion farmaceutica, un metodo para su preparacion, y el uso de las mismas para la manufactura de un medicamento
|
AR029851A1
(es)
|
2000-07-21 |
2003-07-16 |
Dendreon Corp |
Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de hepatitis c
|
PL206255B1
(pl)
|
2000-07-21 |
2010-07-30 |
Dendreon Corporationdendreon Corporation |
Inhibitor proteazy wirusa zapalenia wątroby C, zawierająca go kompozycja farmaceutyczna i zastosowanie inhibitora do wytwarzania leku do leczenia chorób związanych z HCV oraz zastosowanie do wytwarzania kompozycji do stosowania w kombinowanej terapii
|
CZ2003195A3
(cs)
|
2000-07-21 |
2003-04-16 |
Schering Corporation |
Peptidové inhibitory serinové proteázy NS3 a farmaceutický prostředek
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
US6846806B2
(en)
|
2000-10-23 |
2005-01-25 |
Bristol-Myers Squibb Company |
Peptide inhibitors of Hepatitis C virus NS3 protein
|
DE60119968T2
(de)
|
2000-11-20 |
2007-01-18 |
Bristol-Myers Squibb Co. |
Hepatitis c tripeptid inhibitoren
|
AU2002230763A1
(en)
|
2000-12-13 |
2008-01-03 |
Bristol-Myers Squibb Pharma Company |
Inhibitors of hepatitis c virus ns3 protease
|
WO2002048157A2
(en)
|
2000-12-13 |
2002-06-20 |
Bristol-Myers Squibb Pharma Company |
Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors
|
GB0107924D0
(en)
|
2001-03-29 |
2001-05-23 |
Angeletti P Ist Richerche Bio |
Inhibitor of hepatitis C virus NS3 protease
|
KR100798579B1
(ko)
|
2001-03-31 |
2008-01-28 |
동화약품공업주식회사 |
신규의 메톡시-1,3,5-트리아진 유도체 및 그를 포함하는약학적 조성물
|
PT1401825E
(pt)
|
2001-06-11 |
2009-10-23 |
Virochem Pharma Inc |
Compostos e métodos para o tratamento ou para a prevenção de infecções com flavivírus
|
AR035543A1
(es)
|
2001-06-26 |
2004-06-16 |
Japan Tobacco Inc |
Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
|
KR100713137B1
(ko)
|
2001-06-28 |
2007-05-02 |
동화약품공업주식회사 |
신규의 2,4-디플루오로벤즈아미드 유도체
|
EP1404704B9
(en)
|
2001-07-11 |
2008-02-20 |
Vertex Pharmaceuticals Incorporated |
Bridged bicyclic serine protease inhibitors
|
WO2003007945A1
(en)
|
2001-07-20 |
2003-01-30 |
Boehringer Ingelheim (Canada) Ltd. |
Viral polymerase inhibitors
|
EP2335700A1
(en)
|
2001-07-25 |
2011-06-22 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis C virus polymerase inhibitors with a heterobicylic structure
|
EP1429759A4
(en)
|
2001-09-26 |
2004-12-15 |
Bristol Myers Squibb Co |
COMPOUNDS FOR TREATING HEPATITIS C VIRUS
|
EP1440068A1
(en)
|
2001-11-02 |
2004-07-28 |
Glaxo Group Limited |
Acyl dihydro pyrrole derivatives as hcv inhibitors
|
JP2005511573A
(ja)
|
2001-11-02 |
2005-04-28 |
グラクソ グループ リミテッド |
Hcv阻害剤としての4−(5−員)−ヘテロアリールアシルピロリジン誘導体
|
EP1321463B1
(en)
|
2001-12-21 |
2007-08-08 |
Virochem Pharma Inc. |
Thiazole derivatives and their use for the treatment or prevention of Flavivirus infections
|
GB0201179D0
(en)
|
2002-01-18 |
2002-03-06 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
AU2003215826A1
(en)
|
2002-04-01 |
2003-10-13 |
Pfizer Inc. |
Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase
|
KR100516434B1
(ko)
|
2002-04-04 |
2005-09-22 |
(주) 비엔씨바이오팜 |
6-(4-치환된-아닐리노)피리미딘 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
|
TW200400963A
(en)
|
2002-05-21 |
2004-01-16 |
Wyeth Corp |
R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
|
TW200400818A
(en)
|
2002-05-21 |
2004-01-16 |
Wyeth Corp |
Method for the use of pyranoindole derivatives to treat infection with hepatitis C virus
|
US7196111B2
(en)
|
2002-06-04 |
2007-03-27 |
Schering Corporation |
Pyrazolo[1,5a]pyrimidine compounds as antiviral agents
|
US7449488B2
(en)
|
2002-06-04 |
2008-11-11 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
EP1525183A1
(en)
|
2002-07-01 |
2005-04-27 |
Pharmacia & Upjohn Company LLC |
Inhibitors of hcv ns5b polymerase
|
MXPA05000020A
(es)
|
2002-07-01 |
2005-12-05 |
Pharmacia & Upjohn Co Llc |
Inhibidores de polimerasa ns5b de la infeccion del virus de la hepatitis c (hcv).
|
GB0216985D0
(en)
|
2002-07-22 |
2002-08-28 |
Glaxo Group Ltd |
Compounds
|
US7183302B2
(en)
|
2002-08-12 |
2007-02-27 |
Bristol-Myers Squibb Company |
Iminothiazolidinones as inhibitors of HCV replication
|
WO2004091724A1
(en)
|
2002-10-08 |
2004-10-28 |
Wyeth |
Anthranilic acid derivatives useful in treating infection with hepatitis c virus
|
KR100453946B1
(ko)
|
2002-10-11 |
2004-10-20 |
(주) 비엔씨바이오팜 |
6-메틸피리딘 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
|
JP2006506455A
(ja)
|
2002-10-24 |
2006-02-23 |
グラクソ グループ リミテッド |
ウイルス感染症の治療のための1−アシル−ピロリジン誘導体
|
BR0315897A
(pt)
|
2002-11-01 |
2008-05-13 |
Abbott Lab |
agentes antiinfecciosos
|
CA2504344A1
(en)
|
2002-11-01 |
2004-05-21 |
Viropharma Incorporated |
Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
|
US20040097492A1
(en)
|
2002-11-01 |
2004-05-20 |
Pratt John K |
Anti-infective agents
|
US7902203B2
(en)
|
2002-11-01 |
2011-03-08 |
Abbott Laboratories, Inc. |
Anti-infective agents
|
US20040162285A1
(en)
|
2002-11-01 |
2004-08-19 |
Pratt John K. |
Anti-infective agents
|
EP1569929B9
(en)
|
2002-12-10 |
2011-09-14 |
Virochem Pharma Inc. |
Compounds and methods for the treatment or prevention of flavivirus infections
|
US20040192707A1
(en)
|
2002-12-10 |
2004-09-30 |
Laval Chan Chun Kong |
Compounds and methods for the treatment or prevention of Flavivirus infections
|
US7098231B2
(en)
|
2003-01-22 |
2006-08-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
WO2004072243A2
(en)
|
2003-02-07 |
2004-08-26 |
Enanta Pharmaceuticals, Inc. |
Macrocyclic hepatitis c serine protease inhibitors
|
MXPA05008106A
(es)
|
2003-02-18 |
2005-09-21 |
Pfizer |
Inhibidores del virus de la hepatitis c, composiciones y tratamientos que los emplean.
|
US7148226B2
(en)
|
2003-02-21 |
2006-12-12 |
Agouron Pharmaceuticals, Inc. |
Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
|
GB0304494D0
(en)
|
2003-02-27 |
2003-04-02 |
Glaxo Group Ltd |
Compounds
|
EP1607091B1
(en)
|
2003-03-10 |
2009-05-20 |
Mitsubishi Corporation |
Antihepatitis c virus agent and anti-hiv agent
|
GB0307891D0
(en)
|
2003-04-04 |
2003-05-14 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
WO2004092161A1
(en)
|
2003-04-11 |
2004-10-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
KR100502394B1
(ko)
|
2003-06-04 |
2005-07-19 |
(주) 비엔씨바이오팜 |
2-[2-(4-모르포리노)에틸아미노]피리딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물
|
KR100502395B1
(ko)
|
2003-06-04 |
2005-07-19 |
(주) 비엔씨바이오팜 |
4-[4-(4-모르포리노)아닐리노]피리미딘 유도체, 그제조방법 및 이를 포함하는 항바이러스용 약학적 조성물.
|
WO2005014543A1
(ja)
|
2003-08-06 |
2005-02-17 |
Japan Tobacco Inc. |
縮合環化合物及びそのhcvポリメラーゼ阻害剤としての利用
|
WO2005016932A1
(en)
|
2003-08-14 |
2005-02-24 |
Wyeth |
Pyranobenzothiophene derivatives to treat infection with hepatitis c virus
|
US7378414B2
(en)
|
2003-08-25 |
2008-05-27 |
Abbott Laboratories |
Anti-infective agents
|
WO2005019191A2
(en)
|
2003-08-25 |
2005-03-03 |
Abbott Laboratories |
1, 1-dioxido-4h-1,2,4-benzothiadiazine derivate und verwandte verbindungen als inhibitoren der hcv polymerase zur behandlung von hepatitis c
|
US7112601B2
(en)
|
2003-09-11 |
2006-09-26 |
Bristol-Myers Squibb Company |
Cycloalkyl heterocycles for treating hepatitis C virus
|
GB0323845D0
(en)
|
2003-10-10 |
2003-11-12 |
Angeletti P Ist Richerche Bio |
Chemical compounds,compositions and uses
|
US7026339B2
(en)
|
2003-11-07 |
2006-04-11 |
Fan Yang |
Inhibitors of HCV NS5B polymerase
|
JPWO2005049622A1
(ja)
|
2003-11-19 |
2007-06-07 |
日本たばこ産業株式会社 |
5−5員縮合複素環化合物及びそのhcvポリメラーゼ阻害剤としての用途
|
WO2005079799A1
(en)
|
2004-02-13 |
2005-09-01 |
Glaxo Group Limited |
4-acyl-piperazines as anti-viral agents
|
DK1718608T3
(da)
|
2004-02-20 |
2013-10-14 |
Boehringer Ingelheim Int |
Virale polymeraseinhibitorer
|
JP4143669B2
(ja)
|
2004-02-24 |
2008-09-03 |
日本たばこ産業株式会社 |
4環縮合複素環化合物及びそのhcvポリメラーゼ阻害剤としての利用
|
DE602005002357T2
(de)
|
2004-03-26 |
2008-05-29 |
Smithkline Beecham Corp. |
Als antivirale mittel geeignete 4-carboxypyrazolderivate
|
GB0408995D0
(en)
|
2004-04-22 |
2004-05-26 |
Glaxo Group Ltd |
Compounds
|
EP1746888A2
(en)
|
2004-05-13 |
2007-01-31 |
Viropharma Incorporated |
Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
|
GB0413087D0
(en)
|
2004-06-11 |
2004-07-14 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
EP1771169A1
(en)
|
2004-07-14 |
2007-04-11 |
PTC Therapeutics, Inc. |
Methods for treating hepatitis c
|
PE20060569A1
(es)
|
2004-07-16 |
2006-06-22 |
Boehringer Ingelheim Int |
Compuestos de indol carbonilamino como inhibidores de la polimerasa ne5b del vhc
|
GB0416396D0
(en)
|
2004-07-22 |
2004-08-25 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
NZ553329A
(en)
|
2004-07-22 |
2010-09-30 |
Ptc Therapeutics Inc |
Thienopyridines for treating hepatitis C
|
KR100638709B1
(ko)
|
2004-07-28 |
2006-10-25 |
(주) 비엔씨바이오팜 |
N-치환된- 설파모일벤조산 유도체, 그 제조방법 및이를 포함하는 항바이러스용 약학적 조성물
|
US7153848B2
(en)
|
2004-08-09 |
2006-12-26 |
Bristol-Myers Squibb Company |
Inhibitors of HCV replication
|
WO2006018725A1
(en)
|
2004-08-18 |
2006-02-23 |
Pfizer Inc. |
Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
|
RU2007110531A
(ru)
|
2004-08-23 |
2008-09-27 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Гетероциклические противовирусные соединения
|
GB0419850D0
(en)
|
2004-09-07 |
2004-10-13 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
US7250441B2
(en)
|
2004-09-23 |
2007-07-31 |
Wyeth |
Carbazole and cyclopentaindole derivatives to treat infection with Hepatitis C virus
|
GB0423673D0
(en)
|
2004-10-25 |
2004-11-24 |
Glaxo Group Ltd |
Compounds
|
GB0423672D0
(en)
|
2004-10-25 |
2004-11-24 |
Glaxo Group Ltd |
Compounds
|
CA2585084A1
(en)
|
2004-10-26 |
2006-05-04 |
Immacolata Conte |
Tetracyclic indole derivatives as antiviral agents
|
CA2585383A1
(en)
|
2004-10-29 |
2006-05-11 |
Gerald W. Shipps, Jr. |
Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents
|
US7659263B2
(en)
|
2004-11-12 |
2010-02-09 |
Japan Tobacco Inc. |
Thienopyrrole compound and use thereof as HCV polymerase inhibitor
|
WO2006065590A2
(en)
|
2004-12-16 |
2006-06-22 |
Xtl Biopharmaceuticals Inc. |
Pyridine and pyrimidine antiviral compositions
|
JP2008526687A
(ja)
|
2004-12-17 |
2008-07-24 |
アナディス ファーマシューティカルズ インク |
ピリダジノン化合物
|
US8329703B2
(en)
|
2005-02-15 |
2012-12-11 |
Xtl Biopharmaceuticals Ltd. |
Pyrazole compounds
|
US20060217390A1
(en)
|
2005-02-24 |
2006-09-28 |
Esmir Gunic |
Cycloalkl, aryl and heteroaryl amino isothiazoles for the treatment of Hepatitis C virus
|
WO2006093801A1
(en)
|
2005-02-25 |
2006-09-08 |
Abbott Laboratories |
Thiadiazine derivatives useful as anti-infective agents
|
GB0505735D0
(en)
|
2005-03-21 |
2005-04-27 |
Glaxo Group Ltd |
Compounds
|
US20060223834A1
(en)
|
2005-04-04 |
2006-10-05 |
Vasu Nair |
Diketo acids on nucleobase scaffolds as inhibitors of Flaviviridae
|
CN101189230A
(zh)
|
2005-05-04 |
2008-05-28 |
弗·哈夫曼-拉罗切有限公司 |
抗病毒的杂环化合物
|
GB0509326D0
(en)
|
2005-05-09 |
2005-06-15 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
JP5030947B2
(ja)
|
2005-05-13 |
2012-09-19 |
ヴァイロケム・ファーマ・インコーポレーテッド |
フラビウイルス感染の治療及び予防のための化合物及び方法
|
US7994360B2
(en)
|
2005-05-16 |
2011-08-09 |
Xtl Biopharmaceuticals Ltd. |
Benzofuran compounds
|
MA28394B1
(fr)
|
2005-06-24 |
2007-01-02 |
Genelabs Tech Inc |
Derives d'heteroaryle pour traitement des virus
|
KR100700676B1
(ko)
|
2005-06-24 |
2007-03-28 |
(주) 비엔씨바이오팜 |
6―(4―치환된―아닐리노)피리미딘 유도체, 그 제조방법및 이를 포함하는 항바이러스용 약학적 조성물
|
CA2613354A1
(en)
|
2005-06-24 |
2007-01-04 |
Migenix Inc. |
Non-nucleoside anti-hepacivirus agents and uses thereof
|
US20070032522A1
(en)
|
2005-07-01 |
2007-02-08 |
Kumar Dange V |
Antiviral agents
|
US20070032488A1
(en)
|
2005-08-05 |
2007-02-08 |
Genelabs Technologies, Inc. |
6-Membered aryl and heteroaryl derivatives for treating viruses
|
US8076365B2
(en)
|
2005-08-12 |
2011-12-13 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
EP1928878A1
(en)
|
2005-08-24 |
2008-06-11 |
Pfizer Inc. |
Methods for the preparation of hcv polymerase inhibitors
|
AR055395A1
(es)
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
WO2007028789A1
(en)
|
2005-09-07 |
2007-03-15 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Quinazoline derivatives as antiviral agents
|
AU2005336627A1
(en)
|
2005-09-19 |
2007-03-29 |
Arrow Therapeutics Limited |
Benzodiazepine derivatives for treating hepatitis C infection
|
GB0519485D0
(en)
|
2005-09-23 |
2005-11-02 |
Glaxo Group Ltd |
Compounds
|
US7754685B2
(en)
|
2005-09-30 |
2010-07-13 |
Scynexis, Inc. |
Methods and pharmaceutical compositions for the treatment and prevention of hepatitis C infection
|
EP1971599A1
(en)
|
2005-12-22 |
2008-09-24 |
SmithKline Beecham Corporation |
Antiviral 2-carboxy-thiophene compounds
|
WO2007082554A1
(en)
|
2006-01-23 |
2007-07-26 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Modulators of hcv replication
|
GB0602046D0
(en)
|
2006-02-01 |
2006-03-15 |
Smithkline Beecham Corp |
Compounds
|
US20070225344A1
(en)
|
2006-02-08 |
2007-09-27 |
Ariamala Gopalsamy |
Sulfonamide derivatives to treat infection with hepatitis C virus
|
US7456166B2
(en)
|
2006-05-17 |
2008-11-25 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
US7521441B2
(en)
|
2006-05-22 |
2009-04-21 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
US7521442B2
(en)
|
2006-05-25 |
2009-04-21 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
JP5205370B2
(ja)
|
2006-05-25 |
2013-06-05 |
ブリストル−マイヤーズ スクイブ カンパニー |
シクロプロピル縮合インドロベンゾアゼピンhcvns5b阻害剤
|
US7452876B2
(en)
|
2006-06-08 |
2008-11-18 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
WO2007147794A1
(en)
|
2006-06-19 |
2007-12-27 |
Smithkline Beecham Corporation |
Furan derivatives and their use as antiviral agents
|
US7462611B2
(en)
|
2006-06-22 |
2008-12-09 |
Anadys Pharmaceuticals, Inc. |
Pyrro[1,2-b]pyridazinone compounds
|
MX2009000513A
(es)
|
2006-07-14 |
2009-03-09 |
Genelabs Tech Inc |
Agentes antivirales.
|
US7662958B2
(en)
|
2006-07-19 |
2010-02-16 |
Rolf Wagner |
Anti-infective agents
|
US20080045498A1
(en)
|
2006-07-20 |
2008-02-21 |
Genelabs Technologies, Inc. |
Polycyclic viral inhibitors
|
WO2008009078A2
(en)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
|
US8329159B2
(en)
|
2006-08-11 |
2012-12-11 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
US7659270B2
(en)
|
2006-08-11 |
2010-02-09 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
JP2010500978A
(ja)
|
2006-08-17 |
2010-01-14 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ウイルスポリメラーゼインヒビター
|